JOURNAL OF RHEUMATOLOGY, cilt.42, sa.12, ss.2354-2360, 2015 (SCI-Expanded, Scopus)
Objective. In this study, we aimed to address the prevalence of fatigue, its associated factors, and the effect of tumor necrosis factor inhibitors (TNFi) on this subgroup of patients in a large axial spondyloarthritis (axSpA) cohort.